Baylor University Medical Center at Dallas, a part of Baylor Scott & White Health, today announces that a third family has welcomed a baby after the mother participated in a landmark uterus transplant clinical trial.
On Aug. 16, the U.S. Food and Drug Administration (FDA) approved a minimally invasive open-heart surgery alternative for low surgical-risk patients following the successful outcome of the PARTNER 3 and Evolut LR clinical trials. Baylor Scott & White The Heart Hospital – Plano and Baylor Scott & White Medical Center – Temple participated in the PARTNER 3 trial and Baylor Scott & White Heart and Vascular Hospital – Dallas participated in the Evolut LR trial, following FDA approval of transcatheter aortic valve replacement (TAVR) for inoperable patients in 2012, high-risk patients in 2014 and medium-risk patients in 2017.
Baylor Scott & White Health now offers a new, more convenient prescription pickup option for patients. Baylor Scott & White Pharmacy kiosks, which are located on medical centers throughout the healthcare system’s service area, are now being installed offsite to make filling prescriptions easier for more patients.
Baylor Scott & White Medical Center – Temple celebrated the completion of its new Grobowsky Surgical Center with a ribbon-cutting event. Scheduled to open in April, the three-story, 147,000 square-foot surgical center expands the hospital’s advanced surgical capabilities for patients undergoing procedures in Central Texas.
Baylor Scott & White Health today opened its newest medical center, Baylor Scott & White Medical Center – Pflugerville, the system’s first hospital constructed in Travis County. The new medical center, at 2600 E. Pflugerville Pkwy, Suite 100, Pflugerville, TX 78660, now offers inpatient hospital services. Baylor Scott & White Health has also opened primary care and specialty care clinics to serve local patients.
Baylor Scott & White Health is announced today on a new facility with a goal of promoting the community’s health and wellbeing while advancing sports medicine and injury prevention in the Waco area.
Baylor Scott & White Health leads the state of Texas in the number of accolades earned in U.S. News & World Report's "America's Best Hospitals" 2018-19 list, released today. Sixteen Baylor Scott & White hospitals were recognized, with two receiving national rankings.
More than 500 men who suffered with problems urinating due to an enlarged prostate have undergone holmium laser enucleation of the prostate (HoLEP), a minimally invasive procedure, at Scott & White Medical Center – Temple. This innovative urological procedure provides much-needed relief for men with a prostate enlargement, also known as benign prostatic hyperplasia (BPH), a condition that can prevent the bladder from emptying properly and could lead to kidney damage or failure.
Scott & White Medical Center – Temple performed its 500th transcatheter aortic valve replacement (TAVR) procedure on a Waco resident, marking a major program milestone.
Baylor Scott & White Health and Select Medical today announced an expansion of their joint venture into the Austin area with the acquisition of a 36-bed inpatient rehabilitation hospital in Lakeway, Texas, that will be operated under the name Baylor Scott & White Institute for Rehabilitation – Lakeway. The transaction is expected to close by July 1, 2018.
Dr. Giuliano Testa, principal investigator of the uterine transplant clinical trial, has been named to Time Magazine's ‘TIME 100’ – Time’s annual list of the 100 most influential people in the world.
Baylor University Medical Center is the first in North Texas to offer the only FDA approved CAR-T cellular therapy to treat diffuse large B-cell lymphoma. (DLBCL)
Baylor Scott & White Health leaders joined Buda city officials today to celebrate the start of construction on a new medical center set to open in summer 2019.
Baylor Scott & White McLane Children’s Medical Center and Clinics care for children and their families with compassion and quality care, and the newest four-legged staff member, Lorenzo, plans to do the same by motivating and supporting patients with gentle snuggles and a warm heart. Lorenzo, a certified facility dog from Canine Companions for Independence (CCI), who will assist the medical center’s Child Life Program and becomes the first facility dog from CCI to join a Texas pediatric (children's) hospital.
Scott & White Medical Center – Temple, part of Baylor Scott & White, is one of 15 U.S. hospitals selected to participate in the American College of Cardiology Patient Navigator Program: Focus MI Quality Campaign as a “Diplomat Hospital.” This is an expanded version of the original Patient Navigator Program launched in 2013. Scott & White – Temple was one of 35 pioneering hospitals chosen to provide personalized services to heart disease patients to help them avoid a quick return to the hospital.
Baylor Scott & White Medical Center – Carrollton announces a monthly "Walk with a Doc" program, which is a free walking health talk.
140 patients received a life-saving kidney or combined kidney-pancreas transplant in a year
Baylor Scott & White Health – the largest not-for-profit healthcare system in Texas — announced several key additions to its executive leadership team. All four women bring a wealth of experience to their new positions and will play vital roles in shaping the strategic future of the system.
Tawanda Gumbo, MD, an investigator at Baylor Scott & White Research Institute, is among 30 experts worldwide named to a World Health Organization task force on treatment of tuberculosis.
Skin-to-skin contact with mom helps newborns at risk of neonatal hypoglycemia stay out of the neonatal intensive care unit, according to a new study by clinicians at Baylor Scott & White Medical Center — McKinney.
Researchers at Baylor Scott & White Research Institute reveal curcumin has potential to overcome chemoresistance in pancreatic ductal adenocarcinoma, a common but aggressive form of cancer in the pancreas.
A new clinical trial at Baylor Scott & White Research Institute is exploring a novel treatment option for patients with multiple myeloma, a type of cancer formed in bone marrow plasma cells that is considered incurable.
New research detailing the molecular mechanisms involved in the breakdown of the soft tissue discs of the spine has the potential to help millions suffering the debilitating back pain, and may provide opportunities for advanced, minimally invasive treatments.
Aspirin has long been used to help prevent and manage heart disease. However, researchers at Baylor Scott & White Research Institute have discovered another potential benefit –- protection against Barrett’s esophagus, a disorder that causes damage to the esophagus from long-term acid reflux disease, and can help lower associated cancer risk.
A new study by researchers at Baylor Scott & White Research Institute is the first to compare anti-inflammatory benefits of curcumin against a combination of both curcumin and essential turmeric oils.
Researchers at Baylor Institute for Rehabilitation and Baylor Scott & White Research Institute received a grant to participate in a nationwide study to improve post-acute care for patients who have suffered a traumatic brain injury.
Robotic-assisted cardiac and thoracic surgery pairs a surgeon’s skills with advanced robotic technology. Surgeons use minimally invasive techniques, meaning large surgical incisions are not required. The technology translates the surgeon’s hand, wrist and finger movements into precise, real-time movements of surgical instruments inside the patient.
Colorectal cancer patients with certain genetic backgrounds may benefit more from taking aspirin to prevent cancer reoccurrence, based on a study conducted by researchers at the Baylor Scott & White Health Research Institute. The study, published this month in Cancer Prevention Research, examined how aspirin influences the growth of cultured colorectal cancer cells with a variety of different mutational backgrounds and aimed to explain why aspirin is more effective in some patients than others.
A review article in Clinical Cancer Research by Investigators from Baylor Scott & White Research Institute examines the potential for microRNAs – molecules that regulate gene expression – to detect gastrointestinal cancer in blood and other bodily fluids, known as a liquid biopsy.
Researchers at Baylor Scott & White Research Institute identified a new genetic biomarker for colon cancer that may lead to development of more targeted treatment of the disease
A new study conducted by researchers at Baylor University Medical Center at Dallas identified a key interaction between Fusobacterium nucleatum, a bacteria commonly linked to gum disease, and a specific microRNA gene regulator in the gut that led to tumor growth in the colon.
One of last year's major achievements in clinical cancer research and care was a study comparing open and laparoscopic surgery led by James Fleshman, MD, colorectal surgeon on the medical staff and chief of surgery at Baylor University Medical Center.
Baylor Heart and Vascular Services at Fort Worth on Tuesday, November 15, became the first program in Texas to implant the only FDA-approved device designed to prevent blood clots from entering the brain by sealing a hole in the heart. The device is designed to help reduce the risk of recurrent cryptogenic strokes in patients diagnosed with a patent foramen ovale (PFO) – a small opening between the upper chambers of the heart.
Baylor Scott & White Research Institute will be home to one of four new Centers of Research Translation, or CORTs. National Institute of Arthritis and Musculoskeletal and Skin Diseases will fund $8.5 million over five years toward the center’s research, which aims to better understand the development of severe lupus in children and could ultimately lead to new personalized treatments.
The White House and the National Institutes of Health (NIH) have announced Baylor Scott & White Research Institute is joining a five-member research consortium to expand precision medicine research.
A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.
Dr. Jung-Hee Woo, director of Baylor Scott & White’s Central Texas cancer research facility, has been awarded a $3.56 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT). The grant will support Baylor Scott & White Health Research Institute’s Investigational New Drug Production Core Facility.
Scott & White Memorial Hospital – Temple broke ground on an innovative surgical sciences facility that will bring new, advanced procedures to patients in Central Texas. The new facility, slated for opening summer 2018, will be adjacent to the hospital and will increase the hospital’s number of operating room suites from 26 to 32. Existing operating rooms within the hospital will be expanded and refreshed.
A clinical trial exploring a new minimally invasive treatment option for some patients with severe aortic stenosis recently launched at Baylor Jack and Jane Hamilton Heart and Vascular Hospital† . The investigational treatment option is for patients who might have been previously deemed unable to have transcatheter aortic valve replacement (TAVR) due to the large size of their diseased valves.
Venuprasad Poojary, PhD, an associate investigator at Baylor Institute for Immunology Research (BIIR), part of Baylor Scott & White Research Institute, reported this week in the journal Nature Immunology the role of a key protein in the regulatory pathway that is involved in limiting colon inflammation and tumor growth.
Baylor Scott & White Health—the largest not-for-profit health care system in Texas—together with the Dallas Cowboys, today broke ground on a game-changing sports medicine, research and performance facility that will be located at The Star in Frisco, home of the new Dallas Cowboys World Corporate Headquarters.
Baylor Scott & White Research Institute scientists presented breakthrough findings at this year’s Digestive Disease Week® (DDW). DDW is the world’s largest and most prestigious gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Gastroenterologists on the medical staff at Baylor University Medical Center at Dallas are evaluating a new procedure for patients with gastrointestinal (GI) leaks and perforations, a complication that can result from laparoscopic surgery on the esophagus, stomach and small intestines—and outcomes have been promising.
William C. Roberts MD, executive director of the Baylor Heart and Vascular Institute (BHVI), has been awarded the 2016 Lifetime Achievement Award by the American College of Cardiology (ACC) for his contributions to the cardiovascular profession.
New research that may dramatically improve drug development for systemic lupus erythematosus patients published online March 31 in Cell, the most prestigious scientific journal among biologists. The paper, “Personalized Immunomonitoring Uncovers Molecular Networks That Stratify Lupus Patients,” is authored by Dr. Virginia Pascual, principal investigator of the study and researcher at Baylor Institute for Immunology Research, part of Baylor Scott & White Research Institute.
A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient living with a total artificial heart (TAH), a first time event in North Texas. The lifesaving TAH technology, a portable device that pumps blood throughout the body, is used as a "bridge" until a donor heart becomes available.
Baylor College of Medicine and Baylor Scott & White Health have entered into an agreement to expand biomedical research in North and Central Texas. Bringing together the strengths of both institutions, the goal of this collaboration is to accelerate efforts to provide new therapies to the residents of Texas and beyond.
A study conducted by researchers within Baylor Scott & White Research Institute, published this week in The BMJ (formerly the British Medical Journal), shows that women are under-represented among first authors of original research in high impact general medical journals.
Surgical teams at Baylor University Medical Center at Dallas transplanted the 4000th liver in the history of the hospital’s transplant program February 3rd. The milestone is a first for any hospital system in Texas and one that only two other transplant programs in the country have achieved.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right